Inve India ▾

Jupiter Life Line Hospitals share price & results

Jupiter Life Line Hospitals Limited· Healthcare

Results to
Sept 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

Runs 4 multi-specialty tertiary/quaternary hospitals (~1,250 beds) across Thane, Pune, Indore and Dombivli.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue365 ₹ crore+15.5% YoYQuarterly, as filedQuarter to Sept 2026Revenue from operations as filed.
Operating margin26.0 %+1.0 pts YoYOperating profit / revenueQuarter to Sept 2026For the quarter; a change is in percentage points.
Net profit51.0 ₹ crore−7.3% YoYQuarterly, as filedQuarter to Sept 2026Profit after tax as filed.
Return on equity11.65 %−2.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-15.60 %−10.9 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)14.33 %−6.1 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Sept 2026

Guidance

What management said, and what became of it

2 of 3 judged targets kept · 12 open · verdicts reflect calls analysed to Q1 FY27.

Jupiter Life Line Hospitals Limited management guidance track record on Inve: 15 targets tracked across analysed earnings calls (2 achieved, 1 missed, 12 open).

TargetOriginal wordingSaidLatest callVerdict
ARPOB Growth (Thane/Pune)inflation-linked
Call transcript, Q4 FY25 · 12 May 2025		Q4 FY25Q1 FY27:Q1 ARPOB stood at INR 73,500, representing a ~10% growth, driven by case mix, contract renegotiations, and pricing. Continues to exceed inflation.
Call transcript, Q1 FY27 · 3 Aug 2026		Achieved
Dombivli Hospital Operational DateQ1 FY26-27
Call transcript, Q3 FY25 · 7 Feb 2025		Q3 FY25Q1 FY27:Not mentioned; promise already achieved.
Call transcript, Q1 FY27 · 3 Aug 2026		Achieved
Debt for New Hospitalswill not need more debt. Internal accruals and cash reserves will be sufficient
Call transcript, Q3 FY25 · 7 Feb 2025		Q3 FY25Q1 FY27:Maintains net debt of zero but with INR 500 cr gross debt. Future funding from internal accruals, with potential debt only towards end of expansion cycle, within 3x EBITDA ceiling.
Call transcript, Q1 FY27 · 3 Aug 2026		Diluted

Source: Inve Guidance Tracker for Jupiter Life Line Hospitals Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of Jupiter Life Line Hospitals Limited's 15 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 12 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹252.95 +3.67% · +₹8.95

Last close 26 Oct 2026 · NSE · INR · Source: Inve

Performance −83.3% 1Y

₹0.5k₹1.0k₹1.5kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 10 Nov 2025Q3 FY26 — 2 Feb 2026Q4 FY26 — 18 May 2026Q1 FY27 — 3 Aug 2026

1Y: ₹1,511.8 on 24 Oct 2025 → ₹252.95. High ₹1,595.2 (30 Oct 2025), low ₹239.65 (15 Oct 2026).

Previous close
₹244
Market cap
₹8.3k Cr
52-week range
₹239.65 – ₹1,595.2
One year
−83.36%
Price to earnings (TTM to Sept 2026)
43.64×
Return on equity (TTM to Sept 2026)
11.65%

Overview

Symbol
NSE:JLHL
Exchange
NSE
Currency
INR

What Jupiter Life Line Hospitals Limited does

Based on the company's own presentations, annual report and earnings calls.

Jupiter Life Line Hospitals operates multi-specialty tertiary and quaternary care hospitals in Western India, earning revenue from inpatient (IPD) and outpatient (OPD) medical services including cardiology, oncology, orthopaedics, nephrology, neurology, organ transplant and other specialities. Each hospital follows an 'all-hub-no-spoke' model, functioning as a fully equipped, independent centre capable of delivering comprehensive care rather than relying on smaller feeder facilities. The Thane hospital additionally houses a multi-organ transplant centre. The company is expanding via both greenfield hospital construction and brownfield capacity additions at existing sites.

Segments

  • IPD (Inpatient)
  • OPD (Outpatient)
Operating hospitals
4 hospitals — Thane, Pune (Baner), Indore and Dombivli (MMR)
Operational bed capacity
1,248 beds (FY26)
Doctors
1,275
Specialities/departments offered
30+
Hospitals under construction/development
3 greenfield projects — Pune-Bibwewadi, Mira-Bhayandar and BKC (Mumbai)
Operating model
All-Hub-No-Spoke — each hospital is a fully equipped, independent tertiary/quaternary care centre
Company website

How the price took the results

close before → close after

Q1 FY27
−3.8%
3 Aug
Q4 FY26
+0.9%
18 May
Q3 FY26
−4.5%
2 Feb
Q2 FY26
−2.5%
10 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Jupiter Life Line Hospitals Limited

Free account: one company. Everything above stays public.

Write why you follow Jupiter Life Line Hospitals Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse Jupiter Life Line Hospitals Limited

Guides on how to read this kind of business and the numbers that matter.